Intravenous co-amoxiclav to prevent infection after operative vaginal delivery: the ANODE RCT

Intravenous co-amoxiclav to prevent infection after operative vaginal delivery: the ANODE RCT

Background: Sepsis is a leading cause of direct and indirect maternal death in both the UK and globally. All forms of operative delivery are associated with an increased risk of sepsis, and the National Institute for Health and Care Excellence’s guidance recommends the use of prophylactic antibiotic...

Full description

Bibliographic Details
Main Authors: Marian Knight, Virginia Chiocchia, Christopher Partlett, Oliver Rivero-Arias, Xinyang Hua, Ursula Bowler, James Gray, Shan Gray, Kim Hinshaw, Aethele Khunda, Philip Moore, Linda Mottram, Nelly Owino, Dharmintra Pasupathy, Julia Sanders, Abdul H Sultan, Ranee Thakar, Derek Tuffnell, Louise Linsell, Edmund Juszczak
Format: Article
Language:English
Published: NIHR Journals Library 2019-10-01
Series:Health Technology Assessment
Subjects:
OPERATIVE VAGINAL DELIVERY
PROPHYLAXIS
INFECTION
RANDOMISED CONTROLLED TRIAL
Online Access:https://doi.org/10.3310/hta23540

Internet

https://doi.org/10.3310/hta23540

Similar Items